# M4 Organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use Guidance for Industry - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/m4-organization-of-the-common-technical-document-for-the-registration-of-pharmaceuticals-for-human-use-guidance-for-industry/e5a79d19-73aa-4d4c-baa8-342b5ddc7632 > FDA guidance document: M4 Organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use Guidance for Industry. Issue date: October 03, 2017. Get complete insights and analysis. --- ## Details - Title: M4 Organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use Guidance for Industry - Communication Type: Guidance Document - Product Type: drugs - Office Name: Center for Drug Evaluation and Research - Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c - Issue Date: 2017-10-03 - Last Changed: 2020-04-24 - Docket Number: FDA-2017-D-5139 ## Related Documents - [Prescription Drug User Fee Act Waivers, Reductions, and Refunds for Drug and Biological Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/prescription-drug-user-fee-act-waivers-reductions-and-refunds-for-drug-and-biological-products-guidance-for-industry/1a0bec17-eee8-4dda-9b43-4ca488355d7f) - [Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers: Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/expanded-access-to-investigational-drugs-for-treatment-use-questions-and-answers-guidance-for-industry/12e2fbc0-e56f-4be2-8fa3-278d7a366326) - [E2C(R2) Periodic Benefit-Risk Evaluation Report – Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/e2cr2-periodic-benefit-risk-evaluation-report-questions-and-answers/9735c0c5-468e-4e9b-a4c9-a7bad1eb9d94)